Indeed, inhibition of PFKFB3 reduced pathological angiogenesis [39], induced tumor vessel normalization, downregulated glycolytic activity in pericytes, tightened the EC barrier, impaired metastasis and improved chemotherapy [40]. This evidence concerns the gene PFKFB3 and neoplasm.